Domestic pharmaceutical firms should explore foreign markets with better R&D capacity
Published: 2006-09-25 06:56:00
Updated: 2006-09-25 06:56:00
Korean drug makers need to reinforce their research and development (R&D) strategy toward modified new drugs and/or first generics to ensure that firms will be able to survive in the neck-and-neck international competition, said a local expert.
During a local forum organized by the Korea Healt...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
